Maybe a smidge of evidence to support vasodilator use in #scleroderma pts with mPAP 20-24? No change in mPAP with ambrisentan, but there were improvements in PVR, CO. Interesting that none of the pts had PVR>3 at baseline though. #CHESTPulmVasc https
651 followers
264 followers
RT @PH_Papers: Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a r…
1,408 followers
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study). https://t.co/YXDKd9ranh